02587 HEALTHYWAY INC
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.42X | Oper Margin | 4.0% |
|---|---|---|---|
| LT Debt/Equity | 2.3% | Net Margin | 3.6% |
| Total Debt/Equity | 14.9% | Return on Equity | 20.1% |
| Price/Book | 13.78X | Return on Assets | 7.9% |
| (HKD 4.840) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 61.98 | -285.50 | -341.77 | -289.42 | -192.30 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +121.7 | +16.5 | -18.1 | -50.5 | N/A |
| Earnings Per Share (HKD) | 0.071 | -0.399 | -0.488 | N/A | N/A |
| Earnings Per Share Growth (%) | +117.7 | +18.3 | +100.0 | N/A | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 68.56 | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.351 | 0.275 | N/A | N/A | N/A |
| Auditors' Opinion | N/A | Unqualified | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,563 | 1,201 | +30.1 | 1,244 |
| Operating Result | 59.684 | -263.523 | -122.6 | -321.234 |
| Associates | -0.367 | -0.286 | +28.3 | -0.072 |
| Profit Before Taxation | 59.317 | -263.799 | -122.5 | -320.945 |
| Taxation | 4.979 | 5.359 | -7.1 | -7.063 |
| Profit /( Loss) After Taxation | 54.338 | -269.158 | -120.2 | -313.882 |
| Minority Interests | -1.344 | -0.702 | +91.5 | -3.803 |
| Net Profit | 55.682 | -268.456 | -120.7 | -310.079 |
| Earnings Per Share () | 0.0706 | -0.3990 | -117.7 | -0.4884 |
| Announcement Date | 2026-03-30 | 2025-03-28 | NA | 2024-12-18 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
